Rallybio Corporation RLYB
15.86 USD +0.10 (+0.63%)
At closeNov 3, 2026, 4:00 PM EST
15.86 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
15.50 Day range 16.43
3.67 52-week range 17.57
- YTD
- +188.89%
- 1 year
- +197.00%
News
benzinga.com Rallybio Q3 EPS $(0.48) Misses $(0.21) Estimate Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.21) by 128.57 percent. This is a 57.14 percent increase over losses of $(1.12)…
benzinga.com Rallybio Declares $82.7M Special Cash Distribution To Stockholders And Pre-Funded Warrant Holders, Estimated At $13.56/Share, In Connection With Avenzo Therapeutics Merger As previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement")…
businesswire.com Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio…
defenseworld.net Rallybio (NASDAQ:RLYB) Stock Price Up 1.9% – Should You Buy? Shares of Rallybio Corporation (NASDAQ: RLYB - Get Free Report) traded up 1.9% during trading on Friday. The stock traded as high as $17.22 and last traded at $17.08. Approximately 7,854 shares…
gurufocus.com Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026
prnewswire.com Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
gurufocus.com Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 9, 2026
prnewswire.com Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
gurufocus.com Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick and Foti, LLC (âKSFâ) are investigating the proposed merger of
businesswire.com Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio…
prnewswire.com Shareholder Alert: Ademi LLP investigates whether Rallybio Corporation is obtaining a Fair Price for Public Shareholders MILWAUKEE, June 2, 2026 /PRNewswire/ -- Ademi LLP is investigating Rallybio (Nasdaq: RLY) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction…
seekingalpha.com Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript
gurufocus.com RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of
businesswire.com RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of the proposed…
benzinga.com Rallybio To Acquire Avenzo Therapeutics; Avenzo Entered Into $215M Private Placement Financing About the Proposed Transaction Under the terms of the merger agreement, Rallybio will acquire Avenzo pursuant to the Merger. At the closing of the Merger, Avenzo stockholders will receive newly…
businesswire.com Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement NEW HAVEN, Conn. & SAN DIEGO, Calif.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, valuing GME at $55.5B. eBay shares jumped 8.1% to $112.50 in pre-market trading.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
prnewswire.com Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
prnewswire.com Are EWCZ, STEL, RLYB, CTRA Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
globenewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—EWCZ, STEL, RLYB, and CTRA NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders…
globenewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—ALIS, TALK, JTAI, and RLYB NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders…
prnewswire.com Are RLYB, VRME, AES Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
businesswire.com Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio…
seekingalpha.com Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Tiny Biotech Rallybio Stock Surges As $500 Million-Backed Merger Fuels Investor Optimism Rallybio stock jumps after announcing a $505 million merger with Candid Therapeutics, boosting cash to $700 million.
benzinga.com Rallybio To Acquire Candid Therapeutics Under All-Stock Merger Agreement Following closing, pre-Transaction Rallybio equityholders are expected to own approximately 3.65% of the combined company, and pre-Transaction Candid equityholders (inclusive of investors…
benzinga.com Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026 Rallybio reports strong Phase 1 results for RLYB116, showing full immune pathway control with good safety and Phase 2 plans ahead.- benzinga.com Rallybio Reports Results From Phase 1 Confirmatory PK/PD Clinical Trial Evaluating RLYB116 In Development For Patients With Complement-Mediated Diseases With Initial Focus On Immune PTR And Refractory APS – Data Support the Study of RLYB116 as a Potential Best-In-Class Therapeutic for Multiple Complement Mediated Diseases –– Initiation of RLYB116 Phase 2 Clinical Trial in Immune Platelet Transfusion…
benzinga.com Rallybio Announces 1-For-8 Reverse Stock Split Rallybio Corporation (NASDAQ:RLYB) will effect a one-for-eight reverse stock split of its issued and outstanding common stock. Stockholders of Rallybio approved an amendment to Rallybio's Amended and…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com UPDATE: Rallybio Q3 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.21) by 34.58 percent. This is a 46.15 percent increase over losses of $(0.26)…- benzinga.com Rallybio Q3 EPS $0.36 Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate Rallybio (NASDAQ:RLYB) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.21) by 269.01 percent. This is a 238.46 percent increase over losses of $(0.26)…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Rallybio Completes Dosing For First Cohort In Phase 1 Confirmatory PK/PD Study Of RLYB116 Its Once-Weekly, Small-Volume, Subcutaneous C5 Inhibitor Being Developed To Treat Rare Diseases Rallybio Corporation (NASDAQ: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 10.2 percent. This is a 40.54 percent increase over losses of $(0.37) per…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Why Is Microcap Rallybio Stock Trading Higher On Tuesday? Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.- benzinga.com Recursion Acquires Rallybio's Full Interest In Joint ENPP1 Inhibitor Program And Associated Backup Molecule For Treatment Of Hypophosphatasia; Rallybio To Receive $7.5M Upfront, With Potential For $17.5M More In Preclinical And Clinical Milestones Recursion (NASDAQ:RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio's (NASDAQ:RLYB) full interest in their joint…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com Rallybio Initiates Dosing In Phase 1 Confirmatory PK/PD Study Evaluating RLYB116, Subcutaneously Injected C5 Inhibitor – Potential to Address a Broad Range of Complement-Mediated Diseases with Initial Focus on Immune Platelet Transfusion Refractoriness and Refractory Antiphospholipid Syndrome –– Data Readouts…